Viewing Study NCT01064518


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-03-03 @ 3:03 PM
Study NCT ID: NCT01064518
Status: COMPLETED
Last Update Posted: 2020-08-28
First Post: 2010-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Sponsor: Revance Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module